Ohad Goldberg is the Company President at AstraZeneca Israel and a Board Member at Aion Labs, where they focus on pushing the boundaries of science to deliver life-changing medicines in the biopharmaceutical and healthcare sectors. From 2013 to 2016, Ohad held several prominent positions at AstraZeneca, including Market Access Director and Global Launch Leader for Respiratory Biologics. Prior to AstraZeneca, they contributed to Danziger as a Business Development Manager and later as Director of International Sales & Marketing. Ohad has been a member of the Board of Directors at Pharma Israel since 2022 and completed their education at IMD Business School in 2011.
This person is not in any teams
This person is not in any offices